Can a 9‑month‑old infant who has recovered from measles receive the pneumococcal conjugate vaccine (PCV) booster now?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PCV Booster After Measles Recovery in a 9-Month-Old

Yes, you can and should administer the PCV booster to this 9-month-old infant who has recovered from measles. There are no contraindications to giving pneumococcal conjugate vaccine after measles infection, and delaying vaccination would leave the child vulnerable to invasive pneumococcal disease.

Vaccination Schedule for This Child

  • For a 9-month-old infant, the appropriate PCV13 schedule depends on prior vaccination history 1:

    • If the child received 0 doses previously: Administer 2 doses of PCV13 at least 8 weeks apart, followed by a third dose at 12-15 months 1
    • If the child received 1-2 doses before 7 months: Give 1 dose now at 9 months, with a second dose at 12-15 months, at least 8 weeks later 1
  • The minimum interval between doses is 4 weeks for infants under 1 year, though 8 weeks is preferred 1, 2

Key Clinical Considerations

  • Measles infection does not contraindicate PCV administration 3. The child should be clinically recovered from acute measles illness before vaccination, but there is no required waiting period after recovery 3

  • PCV13 can be administered concurrently with other routine vaccines at separate injection sites, including the measles vaccine itself 2, 3

  • Do not delay the vaccination schedule due to the measles infection—continue where the child left off in the PCV series 2

Rationale for Proceeding

  • Post-measles immunosuppression is a concern, but it primarily affects live virus vaccines given shortly after measles infection, not conjugate vaccines like PCV13 3

  • Children recovering from measles may actually be at higher risk for secondary bacterial infections, including invasive pneumococcal disease, making timely PCV vaccination even more important 4

  • The 2p+1 schedule (two primary doses plus booster) is recommended for infants starting vaccination at 7-11 months, with the booster dose given at 9-15 months 1

Common Pitfalls to Avoid

  • Do not restart the vaccination series if there were interruptions—simply continue from where the child left off 2

  • Do not use PPSV23 in this age group; it is only indicated for children ≥2 years with specific high-risk conditions 2

  • Ensure at least 8 weeks have elapsed since the most recent PCV dose before administering the next dose for optimal immune response 1

Related Questions

What are the next steps for a young patient who has received BCG, 2 doses of Hexavalent vaccine, 2 doses of Rotavirus vaccine, and 3 doses of Pneumococcal Conjugate Vaccine?
Is it contraindicated to administer Pneumococcal Conjugate Vaccine (PCV) to a 1-year-old baby who received the Measles vaccine 2 days ago?
What is the correct statement regarding the pneumococcal conjugate vaccine (PCV13) given to an 8-week-old baby?
Can a 2-month-old infant receive Pneumococcal Conjugate Vaccine 20 (PCV20)?
At what age is the Pneumococcal Conjugate Vaccine (PCV) or Pneumococcal Polysaccharide Vaccine (PPSV) no longer necessary for patients who have never received it?
In an 18‑year‑old HIV‑positive patient with uncertain antiretroviral adherence who presents with altered mental status, a seizure with tooth clenching, and a temperature of 37.9 °C, what is the next step in management: emergent non‑contrast head CT, lumbar puncture, or urine toxicology screen?
What is the preferred therapy for PML‑RARA (promyelocytic leukemia‑retinoic acid receptor alpha)‑negative acute promyelocytic leukemia?
What are the common vulvar diseases in post‑menopausal women and their recommended treatments?
What are the recommended anti‑rabies vaccine dosing schedules for pre‑exposure prophylaxis (PrEP) and post‑exposure prophylaxis (PEP), including adjustments for immunocompromised patients and intradermal administration?
What is the recommended first‑line anticoagulation regimen and duration for an adult with an acute deep‑vein thrombosis who has no absolute contraindications to anticoagulation?
How much fluid does an infusion of 100 mL per hour over 24 hours deliver, and is that volume appropriate for a 38‑kg pediatric patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.